Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

This weekend, friends and family of a local mixed martial arts fighter, who died from pancreatic cancer in 2025, will host a ...

Reported 12-month overall survival (OS) in Phase 2a clinical trial nearly double the benchmark from pivotal study of standard ...

Scientists created an immunotherapy that tracks pancreatic cancer even after it spreads. The breakthrough treatment works in ...

Pancreatic ductal adenocarcinoma (PDAC) is both the most common and the deadliest type of pancreatic cancer. Most treatment ...

A tool for spotting pancreatic cancer in routine CT scans has had promising results, one example of how China is racing to ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

The FDA and European Medicines Agency (EMA) have awarded orphan drug designation to CPI-008 (cRGD-ZW800-1), a novel ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

The Krainer lab discovered a three-oncogene circuit that helps drive the aggressive progression of pancreatic ductal ...

An antisense oligonucleotide has been shown to "collapse the entire oncogenic circuit" in pancreatic cancer, triggering ...

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...